BioCryst Pharmaceuticals (BCRX) Fails to deliver data

Key failure to deliver metrics for BioCryst Pharmaceuticals :

• Last SEC data release: 2025-02-14
• Last 15 days FTD volume: N/A
• Last 3 months FTD volume: $0.08 M
• Last year FTD volume: $0.08 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for BioCryst Pharmaceuticals (BCRX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for BioCryst Pharmaceuticals (BCRX) - since 2013

BioCryst Pharmaceuticals (BCRX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Repligen RGEN	$2.92 M	$32.37 M	🇺🇸 USA
Sarepta Therapeutics SRPT	$4.63 M	$36.75 M	🇺🇸 USA
NanoViricides NNVC	$2.6 M	$5.77 M	🇺🇸 USA
Novavax NVAX	$16.12 M	$0.14 B	🇺🇸 USA
Gilead Sciences GILD	$28.08 M	$96.29 M	🇺🇸 USA
Celldex Therapeutics CLDX	$2.04 M	$6.99 M	🇺🇸 USA
GlaxoSmithKline GSK	$81.01 M	$0.17 B	🇬🇧 UK
Emergent BioSolutions EBS	$1.06 M	$6.7 M	🇺🇸 USA
Cel-Sci CVM	$0.6 M	$2.56 M	🇺🇸 USA